Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18 GBX | -1.37% | +1.41% | -32.71% |
30/04 | EARNINGS AND TRADING: Card Factory profit climbs; Pebble "consistent" | AN |
25/03 | OptiBiotix Health raises GBP1.4 million to invest in "driving sales" | AN |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 51.17 | 77.1 | 56.39 | 51.01 | 40.45 | 12.08 |
Enterprise Value (EV) 1 | 49.92 | 75.77 | 56.66 | 50.91 | 39.26 | 11.03 |
P/E ratio | 29.7 x | -39 x | -28.7 x | 9.56 x | 7.02 x | 4.77 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 268 x | 150 x | 82 x | 33.5 x | 18.3 x | 26.4 x |
EV / Revenue | 261 x | 147 x | 82.4 x | 33.4 x | 17.7 x | 24.1 x |
EV / EBITDA | -24.9 x | -55.8 x | -34.8 x | -59 x | -36.5 x | -4.87 x |
EV / FCF | -42.5 x | -59.8 x | - | -49.9 x | -29.1 x | -14.3 x |
FCF Yield | -2.35% | -1.67% | - | -2% | -3.44% | -7% |
Price to Book | 7.26 x | 11 x | 10.9 x | 4.32 x | 2.23 x | 1.11 x |
Nbr of stocks (in thousands) | 79,332 | 84,724 | 85,441 | 87,941 | 87,941 | 91,191 |
Reference price 2 | 0.6450 | 0.9100 | 0.6600 | 0.5800 | 0.4600 | 0.1325 |
Announcement Date | 23/05/18 | 29/04/19 | 28/05/20 | 09/07/21 | 27/06/22 | 23/06/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 0.1911 | 0.5143 | 0.6876 | 1.523 | 2.213 | 0.457 |
EBITDA 1 | -2.007 | -1.357 | -1.628 | -0.8635 | -1.077 | -2.265 |
EBIT 1 | -2.127 | -1.499 | -1.829 | -1.111 | -1.365 | -2.489 |
Operating Margin | -1,113.08% | -291.45% | -265.97% | -72.96% | -61.7% | -544.64% |
Earnings before Tax (EBT) 1 | 1.689 | -1.947 | -2.069 | 5.71 | 6.177 | 2.441 |
Net income 1 | 1.907 | -1.919 | -1.954 | 5.802 | 6.261 | 2.587 |
Net margin | 998.28% | -373.19% | -284.24% | 380.89% | 282.93% | 566.08% |
EPS 2 | 0.0217 | -0.0233 | -0.0230 | 0.0607 | 0.0655 | 0.0278 |
Free Cash Flow 1 | -1.174 | -1.267 | - | -1.021 | -1.351 | -0.7716 |
FCF margin | -614.37% | -246.34% | - | -67% | -61.05% | -168.85% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 23/05/18 | 29/04/19 | 28/05/20 | 09/07/21 | 27/06/22 | 23/06/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 0.27 | - | - | - |
Net Cash position 1 | 1.25 | 1.32 | - | 0.09 | 1.19 | 1.05 |
Leverage (Debt/EBITDA) | - | - | -0.1666 x | - | - | - |
Free Cash Flow 1 | -1.17 | -1.27 | - | -1.02 | -1.35 | -0.77 |
ROE (net income / shareholders' equity) | 31.8% | -26.8% | - | 68.9% | 41.7% | 17.8% |
ROA (Net income/ Total Assets) | -19.9% | -11.9% | - | -6.78% | -5.04% | -9.82% |
Assets 1 | -9.566 | 16.08 | - | -85.6 | -124.2 | -26.35 |
Book Value Per Share 2 | 0.0900 | 0.0800 | 0.0600 | 0.1300 | 0.2100 | 0.1200 |
Cash Flow per Share 2 | 0.0200 | 0.0200 | 0.0100 | 0.0100 | 0.0200 | 0.0100 |
Capex 1 | 0 | 0 | - | - | - | - |
Capex / Sales | 0.94% | 0.57% | - | - | - | - |
Announcement Date | 23/05/18 | 29/04/19 | 28/05/20 | 09/07/21 | 27/06/22 | 23/06/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.71% | 22.32M | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- OPTI Stock
- Financials OptiBiotix Health Plc